For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

Soligenix, Inc.

USPTO Granted Patents = 15

CIPO Patents = 5

EPO Patents = 12

Trademarks = 7

Forward Citations = 16

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Oreola Donini (7 out of 8 patents)

Annett Rozek (5 out of 14 patents)

Jackson Lee (3 out of 3 patents)

4. John North (3 out of 3 patents)

5. Christopher Schaber (3 out of 3 patents)

6. George McDonald (3 out of 3 patents)

7. Michael J Abrams (3 out of 31 patents)

8. Rasappa Gounder Arumugham (2 out of 12 patents)

9. Holger Rauter (2 out of 8 patents)

10. Silvia Werner (2 out of 6 patents)

11. Shannon Wayne Lentz (2 out of 3 patents)

12. Axel Thomas Lehrer (2 out of 3 patents)

13. Robert N Brey (2 out of 3 patents)

14. Theodore W Randolph (1 out of 34 patents)

15. Panayiotis P Constantinides (1 out of 24 patents)

15 patents: Sort by Forward Citations

1. 12097291 - Thermostable vaccine compositions and methods of preparing same (2024-09-24),

2. 11771757 - Compositions and methods of manufacturing trivalent filovirus vaccines (2023-10-03),

3. 11433129 - Compositions and methods of manufacturing trivalent filovirus vaccines (2022-09-06),

4. 11311598 - Peptides and analogs for use in the treatment of oral mucositis (2022-04-26),

5. 10526268 - Systems and methods for producing synthetic hypericin (2020-01-07),

6. 10293041 - Multivalent stable vaccine composition and methods of making same (2019-05-21),

7. 10253068 - Peptides and analogs for use in the treatment of oral mucositis (2019-04-09),

8. 10053413 - Systems and methods for producing synthetic hypericin (2018-08-21),

9. 9850279 - Peptides and analogs for use in the treatment of oral mucositis (2017-12-26),

10. 9763963 - Topically active steroids for use in interstitial pulmonary fibrosis (2017-09-19),

11. 9416157 - Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity (2016-08-16),

12. 9168263 - Topically active steroids for use in interstitial pulmonary fibrosis (2015-10-27),

13. 8791061 - Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity (2014-07-29),

14. 8535650 - Stabilized reverse micelle compositions and uses thereof (2013-09-17),

15. 8263582 - Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids (2012-09-11),

Soligenix, Inc. is a late-stage biopharmaceutical company that focuses on developing and commercializing innovative products to treat rare diseases. They utilize cutting-edge technologies and scientific expertise to address unmet medical needs, particularly in the areas of oncology, inflammation, and infectious diseases. With a strong pipeline of product candidates, Soligenix aims to improve the quality of life for patients while creating value for its shareholders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

15 Patents

#59 in Princeton, NJ

#805 in New Jersey

#20,399 in US

#38,696 in the World

Princeton, NJ, United States of America

Soligenix, Inc.

Forward Citations = 16

21 inventors:

Oreola Donini (7 out of 8 patents)

Annett Rozek (5 out of 14 patents)

Jackson Lee (3 out of 3 patents)

4. John North (3 out of 3 patents)

5. Christopher Schaber (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…